Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2018 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Use of urinary markers in cancer setting: A literature review.
Chiu L, Wong E, DeAngelis C, Chiu N, Lam H, McDonald R, Pulenzas N, Hamer J, Lao N, Chow E. Chiu L, et al. J Bone Oncol. 2015 Feb 27;4(1):18-23. doi: 10.1016/j.jbo.2015.01.002. eCollection 2015 Mar. J Bone Oncol. 2015. PMID: 26579485 Free PMC article. Review.
In general, urinary markers can be used to detect early signs of bone metastases prior to skeletal imaging, but still must be used in conjunction with imaging to avoid false positive results. The use of urinary markers, such as N-telopeptide, as a prognostic tool remains c …
In general, urinary markers can be used to detect early signs of bone metastases prior to skeletal imaging, but still must be used in conjun …
A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting.
Ganesh V, Drost L, DeAngelis C, Wan BA, Pasetka M, Chan S, Zhang L, Tsao M, Barnes E, Pulenzas N, Chung H, Zaki P, Yee C, Chow E. Ganesh V, et al. Ann Palliat Med. 2018 Apr;7(2):211-220. doi: 10.21037/apm.2018.03.12. Ann Palliat Med. 2018. PMID: 29764183 Free article.
QOL was assessed with the Functional Living Index-Emesis and the European Organisation for Research and Treatment of Cancer QOL Questionnaire-Core 15 Palliative (C15-PAL). RESULTS: In all evaluable patients (n=75), complete control of vomiting was 93.3% in the acute phase …
QOL was assessed with the Functional Living Index-Emesis and the European Organisation for Research and Treatment of Cancer QOL Questionnair …
Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
Doubelt I, Pulenzas N, Carette S, Pagnoux C; Canadian Vasculitis Network (CanVasc). Doubelt I, et al. Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):171-175. Epub 2020 Mar 11. Clin Exp Rheumatol. 2020. PMID: 32167871 Free article.
RESULTS: Among 110 cohort patients, 24 with relapsing or refractory EGPA met eligibility criteria. Conventional immunosuppressants used were methotrexate (n=15), azathioprine (n=8) or leflunomide (n=1). Remission rates at 24-weeks were 8.3% with prednisone 4m …
RESULTS: Among 110 cohort patients, 24 with relapsing or refractory EGPA met eligibility criteria. Conventional immunosuppressants used were …
Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30.
Cramarossa G, Zeng L, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Sahgal A, Lam H, Pulenzas N, Chow E. Cramarossa G, et al. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):139-46. doi: 10.1586/14737167.2014.864560. Epub 2013 Dec 10. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24325545
RESULTS: Worse role functioning, social functioning, fatigue and financial problems were the most significant predictive factors for worse QoL. In the bone metastases subgroup (n = 400), role functioning, fatigue and financial problems were the most significant predictors. …
RESULTS: Worse role functioning, social functioning, fatigue and financial problems were the most significant predictive factors for worse Q …
Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study.
Ganesh V, Chan S, Zhang L, Drost L, DeAngelis C, Wan BA, Pasetka M, Tsao M, Barnes E, Pulenzas N, Chung H, Zaki P, Yee C, Chow E. Ganesh V, et al. Ann Palliat Med. 2018 Oct;7(4):385-392. doi: 10.21037/apm.2018.05.10. Epub 2018 Jun 25. Ann Palliat Med. 2018. PMID: 30180723 Free article.
RESULTS: Fourteen patients were enrolled. Rates of control were higher in the acute phase (n=14) for nausea (PR =42.9%, CP =42.9%) and vomiting (PR =21.4%, CP =71.4%) compared to the delayed phase (n=13) for nausea (PR =42.9%, CP =7.7%) and vomiting (PR =15.4%, CP = …
RESULTS: Fourteen patients were enrolled. Rates of control were higher in the acute phase (n=14) for nausea (PR =42.9%, CP =42.9%) an …